Arkolith/Insider Trading/INTS/Form 4

Talamo Joseph

Chief Financial OfficerINTENSITY THERAPEUTICS, INC. (INTS) · full profile →Form 4 · filed Jul 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2025Grant(A)14K$0.26$4K14K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567264-25-000065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML